 | James F FriesShow email address6 Department of Medicine School of Medicine Stanford University Stanford CA. | Department of Medicine, Stanford School of Medicine, Stanford, CA, United States of America. ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
James F Fries:Expert Impact
Concepts for whichJames F Frieshas direct influence:Rheumatoid arthritis,Physical function,Systemic lupus erythematosus,Compression morbidity,Patients rheumatoid arthritis,Arthritis rheumatoid,Cumulative disability.
James F Fries:KOL impact
Concepts related to the work of other authors for whichfor which James F Fries has influence:Rheumatoid arthritis,Systemic lupus erythematosus,Sle patients,Lupus nephritis,Physical activity,Synovial fluid,Rheumatic diseases.
KOL Resume for James F Fries
| Year | |
|---|---|
| 2018 | 6 Department of Medicine School of Medicine Stanford University Stanford CA. Department of Medicine, Stanford School of Medicine, Stanford, CA, United States of America. Electronic address: |
| 2017 | From Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (N.B.A., L.Z., L.L., K.L., T.-H.V., J.S., D.M.L.-J.); Institute of Minority Health Research, University of Illinois College of Medicine, Chicago (M.D., D.G.); Department of Medicine, Stanford School of Medicine, CA (J.F.); and Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston (Y.-C.S.). Department of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA USA |
| 2016 | Stanford University, Stanford, California. |
| 2015 | Stanford University, Palo Alto, CA, USA |
| 2014 | Department of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA Stanford University Palo Alto California |
| 2013 | From the Department of Medicine, Stanford University School of Medicine, Stanford, California; National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland, USA; Medical School Charité, University Medicine Berlin, Berlin, Germany; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA. Stanford ARAMIS Program, Stanford University School of Medicine, Palo Alto, California, USA |
| 2012 | Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, Calif Department of Medicine, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304, USA. |
| 2011 | Department of Medicine, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Stanford, CA 94304, USA |
| 2010 | Department of Medicine, Stanford University, Palo Alto, CA, USA |
| 2009 | Stanford University School of Medicine, Palo Alto, CA 94304, USA. |
| 2008 | Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California Stanford University, Palo Alto, CA |
| 2007 | From the *Evanston Northwestern Healthcare, Evanston, Illinois; †Northwestern University Feinberg School of Medicine, Chicago, Illinois; ‡National Cancer Institute, Bethesda, Maryland; §Samueli Institute, Alexandria, Virginia; ¶Department of Medicine, Stanford University School of Medicine, Stanford, California; and ∥Health Assessment Lab, Boston, Massachusetts. Stanford University Medical Center, Palo Alto, California (Drs Hubert, Lingala, and Fries) |
| 2006 | Health Assessment Lab, Waltham, MA, USA Professor of Medicine |
| 2005 | Department of Medicine, Stanford University School of Medicine, Stanford, California, USA |
| 2004 | Division of Immunology, Department of Medicine, Stanford University, Palo Alto, CA, USA Department of Medicine, Stanford University Medical School, 1000 Welch Road, Suite 203, Palo Alto, CA 94304 Stanford University School of Medicine, Palo Alto, CA |
| 2003 | Stanford University School of Medicine, CA, USA. |
| 2002 | Stanford University, 1000 Welch Road, Suite 203, Palo Alto, CA 94304, USA |
| 2001 | Department of Medicine, Stanford University School of Medicine, 1000 Welch Road. Suite 203, 94304, Palo Alto, CA, USA |
| 2000 | Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304-5755, USA |
| 1999 | Department of Medicine, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304-5755, USA. |
| 1998 | Department of Medicine, Stanford University, School of Medicine, California, USA. |
| 1997 | James F. Fries, MD, is a Professor of Medicine in the Department of Medicine Immunology/Rheumatology, Stanford University, Palo Alto, California. Technology Assessment Group, San Francisco, CA, USA |
| 1996 | Stanford University, Stanford, CA |
| 1995 | *Department of Economics, San Jose State University, San Jose, California †Department of Medicine, Division of Immunology, Stanford University, Stanford, California ‡Department of Economics, Georgia State University, Atlanta, Georgia, U.S.A. From the Stanford University, Stanford California, USA American College of Rheumatology Diagnostic, and Therapeutic Criteria Committee |
| 1994 | Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, U.S.A. Stanford University School of Medicine, California. American College of Rheumatology, 60 Executive Park South, Suite 150, Atlanta, GA 30329 |
| 1993 | Department of Medicine, University School of Medicine, Stanford, Calif. Division of Immunology and Rheumatology, Stanford University Medical Center, 1000 Welch Road, Suite 203, Palo Alto, CA 94304–1808 Stanford University School of Medicine, California |
| 1992 | Department of Economics, San Jose State University, CA 95192-0144. Rheumatic Disease Unit and the Clinical Epidemiology Unit, Wellesley Hospital, University of Toronto, Toronto, Ontario, Canada Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94304. |
| Concept | World rank |
|---|---|
| logical interrelationships criteria | #1 |
| sideeffects 23fold | #1 |
| drug combinations toxicity | #1 |
| disability disease symptoms | #1 |
| olderaged runners | #1 |
| expectancy daily living | #1 |
| gold malignancy | #1 |
| disabled persons bmi | #1 |
| members runners | #1 |
| instruments improved | #1 |
| disability survival benefits | #1 |
| musculoskeletal pain age | #1 |
| sle specific measures | #1 |
| lumbar bone density | #1 |
| rheumatologists lower rates | #1 |
| thoughtful article | #1 |
| aidshaq persons | #1 |
| respect arthritis | #1 |
| direct costs highrisk | #1 |
| techniques weighting | #1 |
| associations subsequent disability | #1 |
| health expenditures stanford | #1 |
| goldtreated patients | #1 |
| epidemiological follow | #1 |
| total knee score | #1 |
| respondent judgement | #1 |
| costs thirtytwo programs | #1 |
| aidshaq | #1 |
| separate covariates overestimate | #1 |
| medical supplement coverage | #1 |
| aletaha publication arthritis | #1 |
| controversies responses | #1 |
| senior groups | #1 |
| haq impact | #1 |
| prednisone propensity | #1 |
| previous nsaidrelated events | #1 |
| average disability indices | #1 |
| viewpoint strengths | #1 |
| hospitalizations auranofin | #1 |
| 140000 patient encounters | #1 |
| systemic sclerosis contrast | #1 |
| predictors physical disability | #1 |
| onefourth disability | #1 |
| data fixed effects | #1 |
| soft tissue “amount | #1 |
| malignancy process assessment | #1 |
| traditional pyramid | #1 |
| rheumatoid arthritis survival | #1 |
| tabulations graphical illustrations | #1 |
| discomfort drug effects | #1 |
| Sign-in to see all concepts, it's free! | |
Prominent publications by James F Fries
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic disease that if left untreated may substantially impair physical functioning. Etanercept, infliximab, and adalimumab are tumor necrosis factor (TNF) blockers whose FDA-approved indications in the US include moderate to severe RA. TNF-blocker dose escalation has been well documented in the literature; however, the comparative effectiveness of these agents remains uncertain.
OBJECTIVE: To compare the effectiveness and dose escalation ...
| Known for Dose Escalation | Rheumatoid Arthritis | Etanercept Adalimumab | Monoclonal Antibodies | Treatment Infliximab |
Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States
[ PUBLICATION ]
OBJECTIVE: The number of individuals ages >or=100 years in the US is expected to increase considerably in the future along with the need for arthroplasties. This report focuses on the poorly studied epidemiology and mortality outcomes of arthroplasty among these individuals.
METHODS: We describe the epidemiology of knee and hip arthroplasties among centenarians using data from a large hospital discharge database in the US (the Nationwide Inpatient Sample) during the period 1993 through ...
| Known for Hip Arthroplasty | United States | Nonagenarians Centenarians | Hospital Mortality | Knee Arthroplasties |
CONTEXT: Hydroxychloroquine, a commonly used antirheumatic medication, has hypoglycemic effects and may reduce the risk of diabetes mellitus.
OBJECTIVE: To determine the association between hydroxychloroquine use and the incidence of self-reported diabetes in a cohort of patients with rheumatoid arthritis.
DESIGN, SETTING, AND PATIENTS: A prospective, multicenter observational study of 4905 adults with rheumatoid arthritis (1808 had taken hydroxychloroquine and 3097 had never taken ...
| Known for Rheumatoid Arthritis | Diabetes Patients | Hydroxychloroquine Risk | Mellitus Female Humans | Incidence Rates |
CONTEXT: Abundant evidence links overweight and obesity with impaired health. However, controversies persist as to whether overweight and obesity have additional impact on cardiovascular outcomes independent of their strong associations with established coronary risk factors, eg, high blood pressure and high cholesterol level.
OBJECTIVE: To assess the relation of midlife body mass index with morbidity and mortality outcomes in older age among individuals without and with other major risk ...
| Known for Blood Pressure | Cardiovascular Disease | Mortality Chd | Normal Weight | Risk Hospitalization |
OBJECTIVE: To present an overview of a series of studies in which the clinical validity of the National Institutes of Health's Patient Reported Outcome Measurement Information System (NIH; PROMIS) measures was evaluated, by domain, across six clinical populations.
STUDY DESIGN AND SETTING: Approximately 1,500 individuals at baseline and 1,300 at follow-up completed PROMIS measures. The analyses reported in this issue were conducted post hoc, pooling data across six previous studies, and ...
| Known for Promis Measures | Clinical Validity | Social Function | Negative Affect | Chronic Conditions |
OBJECTIVES: To identify peripheral blood autoantibody and cytokine profiles that characterise clinically relevant subgroups of patients with early rheumatoid arthritis using arthritis antigen microarrays and a multiplex cytokine assay.
METHODS: Serum samples from 56 patients with a diagnosis of rheumatoid arthritis of <6 months' duration were tested. Cytokine profiles were also determined in samples from patients with psoriatic arthritis (PsA) and ankylosing spondylitis (n = 21), and ...
| Known for Early Rheumatoid Arthritis | Proteomic Analysis | Rheumatoid Autoantibodies | Patients Serum Levels | Proinflammatory Cytokines |
OBJECTIVE: To develop and validate a self- or parent-administered instrument for measuring functional status in children with juvenile rheumatoid arthritis (JRA).
METHODS: We adapted the Stanford Health Assessment Questionnaire (HAQ) for use in children ages 1-19 years, by adding several new questions, such that for each functional area, there was at least 1 question relevant to children of all ages. The face validity of the instrument was evaluated by a group of 20 health professionals ...
| Known for Juvenile Rheumatoid Arthritis | Parents Children | Functional Status | Surveys Questionnaires | Cronbachs Alpha |
Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory
[ PUBLICATION ]
INTRODUCTION: The Health Assessment Questionnaire Disability Index (HAQ) and the SF-36 PF-10, among other instruments, yield sensitive and valid Disability (Physical Function) endpoints. Modern techniques, such as Item Response Theory (IRT), now enable development of more precise instruments using improved items. The NIH Patient Reported Outcomes Measurement Information System (PROMIS) is charged with developing improved IRT-based tools. We compared the ability to detect change in ...
| Known for Physical Function | Item Response Theory | Size Requirements | Disability Haq | Nih Patient |
A canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs
[ PUBLICATION ]
OBJECTIVE: We conducted a cost identification analysis on 164 consecutive patients with systemic lupus erythematosus (SLE) who entered the Montreal General Hospital Lupus Registry between January 1977 and January 1990, compared their costs to the population of Quebec, and determined the predictors of cost.
METHODS: In January 1990 and 1991, participants completed questionnaires on health services utilization and on employment history over the preceding 6 months, as well as on functional, ...
| Known for Direct Costs | Systemic Lupus | Patients Sle | Ambulatory Cost | Total Medical |
BACKGROUND: Persons with lower health risks tend to live longer than those with higher health risks, but there has been concern that greater longevity may bring with it greater disability. We performed a longitudinal study to determine whether persons with lower potentially modifiable health risks have more or less cumulative disability.
METHODS: We studied 1741 university alumni who were surveyed first in 1962 (average age, 43 years) and then annually starting in 1986. Strata of high, ...
| Known for Cumulative Disability | Health Risks | Average Age | 75 Years | Persons Exercise |
OBJECTIVES: Patient-reported outcomes (PROs) are essential when evaluating many new treatments in health care; yet, current measures have been limited by a lack of precision, standardization, and comparability of scores across studies and diseases. The Patient-Reported Outcomes Measurement Information System (PROMIS) provides item banks that offer the potential for efficient (minimizes item number without compromising reliability), flexible (enables optional use of interchangeable ...
| Known for Reported Health | Outcome Item | Short Forms | Response Model | Strong Correlations |
Cardiovascular Risk Profile Earlier in Life and Medicare Costs in the Last Year of Life
[ PUBLICATION ]
BACKGROUND: Health care costs are generally highest in the year before death, and much attention has been directed toward reducing costs for end-of-life care. However, it is unknown whether cardiovascular risk profile earlier in life influences health care costs in the last year of life. This study addresses this question.
METHODS: Prospective cohort of adults from the Chicago Heart Association Detection Project in Industry included 6582 participants (40% women), aged 33 to 64 years at ...
| Known for Cardiovascular Risk | Year Life | Health Costs | Blood Pressure | Favorable Levels |
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing.
[ PUBLICATION ]
OBJECTIVE: Assessing self-reported physical function/disability with the Health Assessment Questionnaire Disability Index (HAQ) and other instruments has become central in arthritis research. Item response theory (IRT) and computerized adaptive testing (CAT) techniques can increase reliability and statistical power. IRT-based instruments can improve measurement precision substantially over a wider range of disease severity. These modern methods were applied and the magnitude of ...
| Known for Computerized Adaptive Testing | Physical Function | Short Forms | Haq Promis | Disability Health |
